Trial Profile
Phase I trial investigating the safety and pharmacokinetics of XEN D0501 in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2011
Price :
$35
*
At a glance
- Drugs XEN D0501 (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Pharmacokinetics
- 12 Sep 2011 New trial record